Journal ArticleOPEN ACCESS

Targeted deep sequencing in polycythemia vera and essential thrombocythemia

  • Tefferi A
  • Lasho T
  • Guglielmelli P
  • et al.
Blood Advances (2016) 1(1) 21-30
DOI: 10.1182/bloodadvances.2016000216
N/ACitations
Citations of this article
193Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

More than half of patients with PV or ET harbor DNA mutations/variants other than JAK2/CALR/MPL. The presence of some of these mutations adversely affects overall, leukemia-free, or myelofibrosis-free survival.

Cite

CITATION STYLE

APA

Tefferi, A., Lasho, T. L., Guglielmelli, P., Finke, C. M., Rotunno, G., Elala, Y., … Vannucchi, A. M. (2016). Targeted deep sequencing in polycythemia vera and essential thrombocythemia. Blood Advances, 1(1), 21–30. https://doi.org/10.1182/bloodadvances.2016000216

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free